Saturday, November 14, 2026

Nikkei 225 Bullish By 5% In The Last 21 Sessions

ViaNews Editorial Team

February 13, 2024

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Nikkei 225 Bullish By 5% In The Last 21 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 5.53% for the last 21 sessions. At 20:08 EST on Monday, 12 February, Nikkei 225 (N225) is $37,543.07.

About Nikkei 225's yearly highs and lows, it's 40.96% up from its 52-week low and 0.24% down from its 52-week high.

Volatility

Nikkei 225's last week, last month's, and last quarter's current intraday variation average was 0.68%, 0.18%, and 0.78%, respectively.

Nikkei 225's highest amplitude of average volatility was 0.75% (last week), 0.67% (last month), and 0.78% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to Zacks on Monday, 12 February, "H&R Block's price performance has roughly matched the S&P 500 over the last year rising +20% to easily top its Zacks Consumer Services-Miscellaneous Market's +2%. "
  • According to Zacks on Monday, 12 February, "The S&P 500 posted 47 new 52-week highs and four new lows, and the Nasdaq Composite recorded 312 new highs and 91 new lows.", "The S&P 500 has reached an all-time high, hitting a record level of 5,000 after a weak start in 2024, with a 1.6% increase in January. "
  • According to FXStreet on Monday, 12 February, "Both the Nasdaq 100 and the S&P 500 refreshed all-time highs, with the latter exploring space north of the 5,000 level (lifted higher on resilient economic activity and disinflation). "
  • According to FXStreet on Monday, 12 February, "The S&P 500 hit a new record high after the US Bureau of Labor Statistics (BLS) reported that it revised the monthly Consumer Price Index (CPI) increase for December lower to 0.2% from 0.3%. "
  • According to FXStreet on Monday, 12 February, "The S&P 500 (SPX) index is trading near Friday's closing level at 5,027.46, the Dow Jones (DJIA) is little changed at 38,653.5, and the Nasdaq (IXIC) gains 0.11% to trade at 16,008.1 at the time of writing."

More news about Nikkei 225 (N225).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com